Table 3.
|
Sickness fund perspective |
Societal perspective |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CLL group |
Control group |
Costs attributable to CLL |
|
CLL group |
Control group |
Costs attributable to CLL |
|
||||||||
Mean | STD | Mean | STD | Lower limit (2.5%) | Mean | Upper limit (97.5%) | p-Value | Mean | STD | Mean | STD | Lower limit (2.5%) | Mean | Upper limit (97.5%) | p-Value | |
Direct medical costs |
€9331 |
(19,795) |
€4533 |
(15,085) |
€4365 |
€4798 |
€5233 |
<.001a |
€9221 |
(19,569) |
€4617 |
(15,080) |
€4173 |
€4604 |
€5038 |
<.001a |
Outpatient cost |
€1699 |
(3748) |
€1246 |
(4304) |
€370 |
€453 |
€544 |
0.873 (Logit)<.001 (Gamma)b |
€1735 |
(3747) |
€1281 |
(4305) |
€372 |
€455 |
€545 |
0.545 (Logit) |
<.001 (Gamma)b | ||||||||||||||||
Inpatient cost |
€3453 |
(11,793) |
€1109 |
(4178) |
€2069 |
€2344 |
€2602 |
<.001 (Logit)0.267 (Gamma)b |
€3663 |
(12,399) |
€1185 |
(4425) |
€2190 |
€2478 |
€2750 |
<.001 (Logit) |
0.156 (Gamma)b | ||||||||||||||||
Pharmaceuticals |
€2699 |
(7469) |
€568 |
(1989) |
€1963 |
€2131 |
€2297 |
0.816 (Logit)<.001 (Gamma)b |
€2342 |
(6308) |
€541 |
(1699) |
€1659 |
€1801 |
€1941 |
0.843 (Logit) |
<.001 (Gamma)b | ||||||||||||||||
Nursing care (at home) |
€858 |
(9951) |
€1035 |
(11,822) |
-€382 |
-€177 |
€52 |
0.104 (Logit)0.900 (Gamma)b |
€858 |
(9951) |
€1035 |
(11,822) |
-€382 |
-€177 |
€52 |
0.104 (Logit) |
0.900 (Gamma)b | ||||||||||||||||
Dentistry |
€156 |
(0) |
€156 |
(0) |
|
€0 |
|
|
€156 |
(0) |
€156 |
(0) |
|
€0 |
|
|
Other |
€466 |
(2111) |
€418 |
(2082) |
€4 |
€48 |
€98 |
0.508 (Logit)0.813 (Gamma)b |
€466 |
(2111) |
€418 |
(2082) |
€4 |
€48 |
€98 |
0.508 (Logit) |
0.813 (Gamma)b | ||||||||||||||||
Direct non-medical costs |
€231 |
(1558) |
€84 |
(754) |
€113 |
€147 |
€191 |
<.001 (Logit) 0.116 (Gamma)b |
€117 |
(759) |
€58 |
(476) |
€44 |
€59 |
€78 |
<.001 (Logit) |
0.923 (Gamma)b | ||||||||||||||||
Sick pay |
€114 |
(1340) |
€26 |
(576) |
€60 |
€88 |
€121 |
0.039 (Logit)0.072 (Gamma)b |
€0 |
|
€0 |
|
|
€0 |
|
|
Other |
€117 |
(759) |
€58 |
(476) |
€44 |
€59 |
€78 |
<.001 (Logit)0.923 (Gamma)b |
€117 |
(759) |
€58 |
(476) |
€44 |
€59 |
€78 |
<.001 (Logit) |
0.923 (Gamma)b | ||||||||||||||||
Administration |
€191 |
(0) |
€191 |
(0) |
|
€0 |
|
|
€191 |
(0) |
€191 |
(0) |
|
€0 |
|
|
Indirect cost |
€0 |
|
€0 |
|
|
€0 |
|
|
€4410 |
(8233) |
€1164 |
(4546) |
€3073 |
€3246 |
€3400 |
0.009 (Logit) |
<.001 (Gamma)b | ||||||||||||||||
Total cost | €9753 | (20,199) | €4807 | (15,219) | €4612 | €4946 | €5499 | <.001a | €13,939 | (22,516) | €6030 | (16,037) | €7434 | €7910 | €8392 | <.001a |
CLL Chronic lymphocytic leukemia, STD Standard deviation.
a) Gamma specified model; b) Zero-truncated gamma model.